The interaction of immune checkpoint molecules such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1), or B7-H3 receptor with corresponding ligands on tumor cells inhibits their anti-tumor activities, leading to immune suppression. Here, CTLA4 is linked to neoplasm.